Compare · ACCD vs ARYA
ACCD vs ARYA
Side-by-side comparison of Accolade Inc. (ACCD) and ARYA Sciences Acquisition Corp III (ARYA): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while ARYA operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for ARYA).
- Company
- Accolade Inc.
- ARYA Sciences Acquisition Corp III
- Price
- $7.03+0.00%
- $11.14+4.70%
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest ARYA
- MarketBeat Ranks Stocks with Most Insider Buying in June 2021
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form D filed by ARYA Sciences Acquisition Corp III
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form 4: PERCEPTIVE ADVISORS LLC bought $55,070,983 worth of Common Stock (5,507,063 units at $10.00), increasing direct ownership by 1% to 497,038 units
- SEC Form 4: ALTMAN MICHAEL SETH converted 4,146,500 units into Common Stock
- ARYA Sciences Acquisition Corp III filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status, Regulation FD Discl
- Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome